Business Context and Reporting Period
This Form 6-K filing by Banco Bradesco S.A. (Bradesco) covers the month of April 2026. The report details the completion of a corporate restructuring regarding the consolidation of healthcare businesses within the Bradesco Organization.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on corporate governance and structural changes.
Material Changes
- Merger of Shares Consummated: The merger of shares issued by Bradesco Gestão de Saúde S.A. (BGS) into Bradsaúde S.A. (formerly Odontoprev S.A.) was approved and completed.
- Ownership Structure: BGS is now a wholly-owned subsidiary of Bradsaúde. Bradesco's equity interest in Bradsaúde increased to 91.35% of total and voting capital.
- Exchange Ratio: The previously established exchange ratio was confirmed without adjustments.
- Upcoming Asset Contribution: An extraordinary general meeting for Mediservice Operadora de Planos de Saúde S.A. is scheduled for May 1, 2026, to approve the contribution of Bradsaúde's dental plans portfolio and operational assets/liabilities to Mediservice.
Guidance, Outlook, and Risks
Management indicates that Bradesco will continue to inform shareholders of material developments. The filing includes a standard forward-looking statements disclaimer, noting that future results depend on economic conditions, industry trends, and operating factors, with no guarantee that expected events will occur.
Contingencies: The 91.35% ownership figure does not account for potential exercises of withdrawal rights by dissenting shareholders of Bradsaúde, the term for which expires on May 7, 2026.
Investor Verification Checklist
- Verify the final ownership percentage of Bradsaúde after the May 7, 2026, deadline for dissenting shareholder withdrawal rights.
- Confirm the outcome of the Mediservice extraordinary general meeting scheduled for May 1, 2026.
- Review subsequent filings for the financial impact of the asset contribution to Mediservice.